Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAI plus vinorelbine + cisplatin vs placebo plus vinorelbine + cisplatin in stage IV NSCLC
CTR20160395Phase 3Completed
- Sponsor
- Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carboxyamidotriazole in non-small cell lung cancer (NSCLC), sponsored by Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. Started Mar 2017; status: completed.
02
Drugs
carboxyamidotriazole
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20160395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160395.